Status:
UNKNOWN
REmote iSchemic Conditioning in acUtE BRAin INfarction Study
Lead Sponsor:
Versailles Hospital
Collaborating Sponsors:
Unité de Recherche Clinique Paris IDF Ouest
Conditions:
Cerebral Infarction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cerebral infarction is the most common form of stroke (80% of strokes). Stroke is the first cause of acquired disability, and the 2nd cause of dementia and death. The only approved treatment in the fi...
Eligibility Criteria
Inclusion
- Patients ≥ 18 years
- Carotid ischemic stroke
- NIHSS score between 5 and 25
- Brain MRI performed within 6 hours from symptoms onset
- Obtaining a written informed consent of the patient or a third party (parent or close), or emergency inclusion process
- Affiliated with a Medicare (or rightful beneficiary)
Exclusion
- Presence of a leg ulcer or a bad skin condition in the lower limbs
- History of arterial occlusive disease of the lower limbs
- Sickle cell disease known (risk of vaso-occlusive crisis)
- History of phlebitis in the lower limbs
- History of cerebral infarction older than 3 months
- Participation in another interventional acute phase protocol
- Patients under guardianship
- Pathologies involving life-threatening within 6 months and making it impossible to evaluate to 3 months
- Patient non-self before the ischemic stroke (Rankin Score previous\> 2)
- Pregnant Women
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02189928
Start Date
January 1 2015
End Date
January 1 2019
Last Update
September 5 2018
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Sud Francilien
Corbeil-Essonne, France, 91100
2
Hôpital Henri Mondor
Créteil, France, 94000
3
Centre Hospitalier de Versailles
Le Chesnay, France, 78150
4
CHU de Nantes
Nantes, France, 44093